Radiation was until recently the key and only modality for the routine treatment of locally
advanced cervical carcinoma. However after years of studying multi-modality treatments as …

The role of neoadjuvant chemotherapy (NACT) in cervical cancer has been a matter of
investigation over the last 20 years. A systematic review and meta-analysis of individual …

Background Our aim was to evaluate the efficacy and safety of neoadjuvant chemotherapy
followed by radical hysterectomy and adjuvant radiation concurrent with weekly cisplatin for …

Background To compare the oncological outcomes of patients with FIGO 2018 stage IIIC
cervical cancer (CC) involving different local tumor factors who underwent abdominal radical …

Cervical cancer is the second most common cancer in women. Neoadjuvant chemotherapy
for patients with locally advanced cervix cancer has comparable benefits to concurrent …

The conventional local treatment methods (surgery and radiation) for cervical cancer have
reached a plateau in terms of survival benefit and, therefore, in this review, new treatment …

The purpose of this study was to evaluate the efficacy and toxicity of neoadjuvant
chemotherapy in patients with locally advanced cervical cancer. Between 1992 and 2003 …

Although the incidence of cervical cancer has declined in both North America and Europe, it
still represents the second most common cancer in women and the fifth most common …

Objectives: Neutral endopeptidase 24.11 (NEP) is known to play important roles in the
maintenance of homeostasis or in neoplastic transformation and tumor progression in …

Objective The CIRCE trial (NCT 01973101) investigated the efficacy, safety, and quality of
life of the addition of neoadjuvant chemotherapy with cisplatin and gemcitabine to standard …